# Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer

> **NCT03879109** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 58 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Chemotherapy FOLFIRINOX, 6 cycles
- **RADIATION:** Radiochemotherapy
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT03879109
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-08
- **Primary completion:** 2024-06-30
- **Final completion:** 2027-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03879109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03879109, "Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03879109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*